GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-x(L) expression

Blood

Volumn 94, Issue 1, 1999, Pages 87-96

  Gregory, Todd ^b   Yu, Channing ^b   Ma, Averil ^b   Orkin, Stuart H ^b   Blobel, Gerd A ^b   Weiss, Mitchell J ^a  

^a Ontogeny Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PROTEIN BCL X;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0033168769     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.87.413k41_87_96     Document Type: Article

References (57)

1. Wood WG: Erythropoiesis and haemoglobin production during development, in Jones CT (ed): Biochemical development of the fetus and neonate. New York, NY, Elsevier Biomedical, 1982, p 127
2. Mucenski ML, McLain K, Kier AB, Swerdlow CM, Schreiner TA, Miller TA, Pietryga DW, Scott WJJ, Potter SS: A functional c-myb gene is required for normal fetal hematopoiesis. Cell 65:677, 1991
3. Ogawa M, Nishikawa S, Yoshinaga K, Hayashi S, Kunisada T, Nakao J, Kina T, Sudo T, Kodama H, Nishikawa S: Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development 117:1089, 1993
4. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
5. Chyuan-Sheng L, Lim S-K, D'Agati V, Costantini F: Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10:154, 1996
6. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA: Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93:3444, 1996
7. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321, 1996
8. Pevny L, Simon MC, Robertson E, Klein WH, Tsai S-F, D'Agati V, Orkin SH, Costantini F: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257, 1991
9. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH: Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA 93: 12355, 1996
10. - embryonic stem cells. Genes Dev 8:1184, 1994
11. Weiss MJ, Orkin SH: Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA 92:9623, 1995
12. Blobel GA, Orkin SH: Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 16:1687, 1996
13. Pevny L, Chyuan-Sheng L, D'Agati V, Simon MC, Orkin SH, Costantini F: Development of hematopoietic cells lacking transcription factor GATA-1. Development 121:163, 1994
14. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH: A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16:3965, 1997
15. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 80:575, 1992
16. Webster NJG, Green S, Rui Jin J, Chambon P: The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transactivation function. Cell 54:199, 1988
17. Weiss MJ, Orkin SH: GATA transcription factors: Key regulators of hematopoiesis. Exp Hematol 23:99, 1995
18. Kelley LL, Koury MJ, Bondurant MC, Koury ST, Sawyer ST, Wickrema A: Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: A mechanism for controlled rates of erythrocyte production. Blood 82:2340, 1993
19. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid cells. Science 248:378, 1990
20. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL: Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88:1576, 1996
21. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH: Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci USA 88:10638, 1991
22. Heberlein C, Fischer KD, Stoffel M, Nowock J, Ford A, Tessmer U, Stocking C: The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation. Mol Cell Biol 12:1815, 1992
23. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
24. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
25. Gregoli PA, Bondurant MC: The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630, 1997
26. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Satoshi F, Loh DY: Massive cell death of immature hematopoietic cells and neurons in Bcl-X-deficient mice. Science 267:1506, 1995
27. Benito A, Silva M, Grillot D, Nunez G, Fernandez-Luna JL: Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood 87:3837, 1996
28. Weiss MJ, Yu C, Orkin SH: Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 17:1642, 1997
29. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH: FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90:109, 1997
30. Kumar V, Hreen S, Staub A, Chambon P: Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5:2231, 1986
31. Briegel K, Lim K-C, Plank C, Beug H, Engel JD, Zenke M: Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 7:1097, 1993
32. Orkin SH, Harosi FI, Leder P: Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci USA 72:98, 1975
33. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW, Thompson CB: Bcl-x regulates the survival double-positive thymocytes. Proc Natl Acad Sci USA 92:4763, 1995
34. Yang XF, Weber GF, Cantor H: A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7:629, 1997
35. Keller G, Kennedy M, Papayannopoulou T, Wiles MV: Hematopoietic differentiation during embryonic stem cell differentiation in culture. Mol Cell Biol 13:472, 1993
36. McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH: A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci USA 94:6781, 1997
37. McClinton D, Stafford J, Brents L, Bender TP, Kuehl WM: Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol Cell Biol 10:705, 1990
38. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455, 1994
39. Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M: p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11540, 1996
40. Fang W, Rivard JJ, Mueller DL, Behrens TW: Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J Immunol 153:4388, 1994
41. L is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120:3033, 1994
42. Socolovsky M, Lodish HF, Daley GQ: Control of hematopoietic differentiation: Lack of specificity in signaling by cytokine receptors. Proc Natl Acad Sci USA 95:6573, 1998
43. Lacombe C, Mayeux P: Biology of erythropoietin. Haematologica 83:724, 1998
44. Comelli M, Londero D, Mavelli I: Severe energy impairment consequent to inactivation of mitochondrial ATP synthase as an early event in cell death: A mechanism for the selective sensitivity to H2O2 of differentiating erythroleukemia cells. Free Radic Biol Med 24:924, 1998
45. White E: Life, death, and the pursuit of apoptosis. Genes Dev 10:1, 1996
46. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322, 1998
47. Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, Nunez G: Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 158:4750, 1997
48. Zhuang H, Niu Z, He TC, Patel SV, Wojchowski DM: Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem 270:14500, 1995
49. Packham G, White EL, Eischen CM, Yang H, Parganas E, Ihle JN, Grillot DA, Zambetti GP, Nunez G, Cleveland JL: Selective regulation of Bcl-XL by a JAK kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 12:2475, 1998
50. Jacobs-Helber SM, Penta K, Sun Z, Lawson A, Sawyer ST: Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J Biol Chem 272:6850, 1997
51. Yoshimura A, D'Andrea AD, Lodish HF: Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci USA 87:4139, 1990
52. Neumann D, Wikstrom L, Watowich SS, Lodish HF: Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes. J Biol Chem 268:13639, 1993
53. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A: Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant RAG-1-/-mice. Cell 89:1011, 1997
54. Lagasse E, Weissman IL: Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021, 1997
55. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL: Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033, 1997
56. Lacronique V, Varlet P, Mayeux P, Porteu A, Gisselbrecht S, Kahn A, Lacombe C: Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90:3050, 1997
57. Orkin SH: Hematopoiesis: How does it happen? Curr Opin Cell Biol 7:870, 1995